📘 : Nexus Global Research Journal of Pharmaceutical Sciences (NGRJPS) Volume 1, Issue 3, 2026 (Page : 89-91)
ABSTRACT:
Diabetic peripheral neuropathy (DPN) is a predominant microvascular complication of diabetes mellitus, affecting nearly half of all patients over the course of their disease [1]. Despite its prevalence, up to 50% of DPN cases remain asymptomatic in the early stages, making the condition a silent precursor to severe complications, including diabetic foot ulcers and lowerextremity amputations [2]. This article reviews the epidemiological burden of DPN, the pronounced deficit in patient awareness regarding nerve health, and the current evidence-based approaches to screening and pharmacological management.
Keywords: Diabetic Peripheral Neuropathy (DPN); Patient Awareness; Painful Diabetic Neuropathy (PDN); Diabetes Complications; Preventive Foot Care; Clinical Screening; Pharmacological Management; Health Literacy.